https://wikimd.org/index.php?action=history&feed=atom&title=Immunomedics 2026-04-27T19:56:40Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Immunomedics&diff=6511153&oldid=prev 2025-03-17T16:10:17Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:10, 17 March 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l31">Line 31:</td> <td colspan="2" class="diff-lineno">Line 31:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{No image}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{No image}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">__NOINDEX__</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Immunomedics&diff=6269807&oldid=prev 2025-02-11T02:01:36Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 02:01, 11 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l30">Line 30:</td> <td colspan="2" class="diff-lineno">Line 30:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmaceutical companies of the United States]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmaceutical companies of the United States]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{No image}}</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Immunomedics&diff=5375288&oldid=prev 2024-03-08T19:02:19Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Immunomedics&#039;&#039;&#039; is a [[biopharmaceutical]] company that specializes in the development of [[monoclonal antibody]]-based products for the targeted treatment of [[cancer]], [[autoimmune disorders]], and other serious diseases. The company&#039;s advanced proprietary technologies allow it to create humanized antibodies that can be used either alone in unlabeled or &quot;naked&quot; form, or conjugated with [[radioisotopes]], [[chemotherapeutics]], or [[toxins]], to create highly targeted agents.<br /> <br /> == History ==<br /> <br /> Immunomedics was founded in 1982 by [[David M. Goldenberg]], a pioneer in the field of [[radioimmunotherapy]]. The company&#039;s initial focus was on the development of monoclonal antibody-based imaging agents, but it soon expanded its research and development efforts to include therapeutic applications of its technologies.<br /> <br /> == Products and Pipeline ==<br /> <br /> Immunomedics&#039; product portfolio includes a number of monoclonal antibodies that are in various stages of clinical development. The company&#039;s lead product, [[Sacituzumab Govitecan]], is a first-in-class antibody-drug conjugate that has shown promise in the treatment of several types of solid tumors.<br /> <br /> In addition to Sacituzumab Govitecan, Immunomedics has several other products in its pipeline, including [[Labetuzumab Govitecan]], a second antibody-drug conjugate that is currently in Phase II clinical trials for the treatment of colorectal cancer.<br /> <br /> == Research and Development ==<br /> <br /> Immunomedics&#039; research and development efforts are focused on the discovery and development of novel monoclonal antibodies and antibody-drug conjugates for the treatment of cancer and other serious diseases. The company&#039;s proprietary technologies, including its [[Dock-and-Lock]] (DNL) platform, allow it to create highly specific and potent therapeutic agents.<br /> <br /> == See Also ==<br /> <br /> * [[Monoclonal antibodies]]<br /> * [[Antibody-drug conjugate]]<br /> * [[Cancer immunotherapy]]<br /> * [[Radioimmunotherapy]]<br /> <br /> == References ==<br /> <br /> &lt;references /&gt;<br /> <br /> [[Category:Biopharmaceutical companies]]<br /> [[Category:Companies established in 1982]]<br /> [[Category:Pharmaceutical companies of the United States]]<br /> {{pharmacology-stub}}</div>

Prab